{"id":"https://openalex.org/keywords/phenprocoumon","display_name":"phenprocoumon","description":"Phenprocoumon is an oral coumarin anticoagulant that reduces blood clotting by inhibiting vitamin K activity.","display_name_alternatives":["Falithrom","3-(1-phenylpropyl)-4-hydroxycoumarin","3-(alpha-ethylbenzyl)-4-hydroxycoumarin","3-(alpha-phenylpropyl)-4-hydroxycoumarin","4-hydroxy-3-(1-phenylpropyl)-2H-chromen-2-one","Liquamar","Marcoumar","phenprocoumarol","phenprocoumarole","phenprocoumone","phenprocumone","Marcumar"],"ids":{"openalex":"https://openalex.org/keywords/phenprocoumon","wikidata":"https://www.wikidata.org/wiki/Q267896"},"primary_topic":null,"topics":[{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.178,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.1528,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.0793,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"works_count":1735,"cited_by_count":25444,"works_api_url":"https://api.openalex.org/works?filter=keywords.id:keywords/phenprocoumon","updated_date":"2026-11-16T04:05:30","created_date":"2022-04-12T19:38:12"}
